by Elizabeth Kissling | Jan 25, 2010 | Birth Control, FemCare, Humor, Internet, Media, Menstruation
We’re sad to learn that brilliant funnywoman Sarah Haskins is leaving Target: Women (and especially sad that she’s leaving before creating a TW about femcare products). But we still have her fine piece about how birth control is sold to us as period...
by Elizabeth Kissling | Dec 18, 2009 | Health Care, Law/Legal, Menopause, Pharmaceutical
You may have heard the news that 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer were dismissed by a New York judge this week. Judge Martin Shulman granted Pfizer’s motion to dismiss for two reasons: the plaintiff’s...
by Elizabeth Kissling | Dec 16, 2009 | Internet, Law/Legal, Media, Menopause, Pharmaceutical
That was Zoe Littlepage’s response to Pfizer’s request to a judge that her law firm remove this video press release about Pfizer’s malfeasance regarding cancer risk of Prempro, their menopause hormone therapy drug. The motion reads, in part,...
by Elizabeth Kissling | Dec 13, 2009 | Advertising, Law/Legal, Media, Menopause
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of...
by Elizabeth Kissling | Dec 11, 2009 | Girls, Health Care, Law/Legal, New Research, Pharmaceutical
Today I want to point to two important articles about women’s health from our friends at Women’s eNews: Yesterday, they published a story about Myriad Genetics and their firm grasp on the patents for diagnostics tests for BRCA1 and BRCA2 genes, which are...
